Neurohypophysial disorders Flashcards
Aetiology of Cranial Diabetes Insipidus
Acquired (more common) or congenital (rare)
-Acquired causes involves damage to the neurohypophysial system
Examples of acquired causes include:
- traumatic brain injury
- pituitary surgery
- pituitary tumours, craniopharyngioma
- metastasis to the pituitary gland
- granulomatous infiltration of the median eminence (eg: Tuberculosis, Sarcoidosis etc)
Aetiology of Nephrogenic Diabetes Insipidus
Acquired or congenital (rare)
Diabetes Insipidus presentation
- Polyuria (large volumes of urine)
- Hypo-osmolar urine (very dilute urine)
- Polydipsia (excessive thirst and increased drinking)
- Dehydration (and consequences) if fluid intake not maintained-> can result in death
- Possible sleep disruption with associated problems
Psychogenic polydipsia
- frequently seen in psychiatric patients (unclear aetiology but may reflect anti-cholinergic effects of medication)
- can be in patients told to ‘drink plenty’ by healthcare professionals
- presents with excess fluid intake (polydipsia) and excess urine output (polyuria)
- differs from Diabets Insipidus as ability to secrete vasopressin in response to osmotic stimuli is preserved
Diabetes Insipidus biochemical features
- Hypernatraemia
- Raised urea
- Increased plasma osmolality
- Dilute (hypo-osmolar) urine
Psychogenic polydipsia biochemical features
- Mild hyponatraemia (excess water intake)
- Low plasma osmolality
- Dilute (hypo-osmolar) urine
Desmopressin
- Administered nasally, orally or subcutaneously
- reduces urine volume and concentration in Cranial Diabetes Insipidus
Selective vasopressin receptor peptidergic agonists
- V1 receptors-> eg: Terlipressin
- V2 receptors-> eg: Desmopressin (DDAVP)
Nephrogenic diabetes insipidus treatment
THIAZIDES (EG: BENDROFLUMETHIAZIDE)
SIADH
SYNDROME OF INAPPROPRIATE ADH
-the plasma vasopressin concentration is inappropriately high for the existing plasma osmolality (excess ADH/Vasopressin)
SIADH signs
- raised urine osmolality
- decreased urine volume initially
- hyponatraemia due largely to increased water reabsorption
SIADH symptoms
- patient can be symptomless
- however, if ……< 120mM, patient experiences generalised weakness, poor mental function and nausea
- if ……< 110mM, patient experiences confusion which can lead to coma and ultimately death
SIADH causes
- CNS (eg: subarachnoid haemorrhage, stroke, tumour, traumatic brain injury)
- Pulmonary disease (eg: pneumonia, bronchiectasis)
- Malignancy (eg: small cell lung cancer)
- Drug-related (eg: Carbamazepine, SSRIs)
- Idiopathic
SIADH treatment
/
Vaptans
NON-COMPETITIVE V2 RECEPTOR ANTAGONISTS
- inhibits AQP2 synthesis and transport to collecting duct apical membrane, preventing renal water reabsorption
- produce aquaresis (solute-sparing renal excretion of water)
- Aquaresis contrasts with diuresis which produces simultaneous electrolyte loss
- licensed in UK for hyponatraemia treatment associated with SIADH
- very expensive (limits current use)